Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Background  





2 Cancer Treatment  





3 Forensics  





4 References  














Nullomers






Deutsch
Français
Galego
Português
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Nullomers are short sequences of DNA that do not occur in the genome of a species (for example, humans), even though they are theoretically possible.[1][2] Nullomers must be under selective pressure - for example, they may be toxic to the cell.[2] Some nullomers have been shown to be useful to treat leukemia, breast, and prostate cancer. They are not useful in healthy cells because normal cells adapt and become immune to them.[2] Nullomers are also being developed for use as DNA tags to prevent cross contamination when analyzing crime scene material.[3]

Background[edit]

Nullomers are naturally available but potentially unused sequences of DNA. Determining these "forbidden" sequences can improve the understanding of the basic rules that govern sequence evolution.[4] Sequencing the entire genome has shown that there is a high level of non-uniformity in genomic sequences. When a codon is artificially substituted for a synonymous codon, it often results in a lethal change and cell death. This is believed to be due to ribosomal stalling and early termination of protein synthesis. For example, both AGA and CGA code for arginine in bacteria; however, bacteria almost never use AGA, and when substituted it proves lethal.[5] Such codon biases have been seen in all species,[6] and are examples of constraints on sequence evolution. Other sequences may have selective pressure; for example, GG-rich sequences are used as sacrificial sinks for oxidative damage because oxidizing agents are attracted to regions with GG-rich sequences and then induce strand breakage.[7] Moreover, it has been shown that statistically significant nullomers (i.e. absent short sequences which are highly expected to exist) in virus genomes are restriction recognition sites indicating that viruses have probably got rid of these motifs to facilitate invasion of bacterial hosts.[8] Nullomers Database provides a comprehensive collection of minimal absent sequences from hundreds of species and viruses as well as the human and mouse proteomes.

Sequence of Human nullomers of 11bp in length[4]
No occurrence in the Human Genome CGCTCGACGTA, GTCCGAGCGTA, CGACGAACGGT, CCGATACGTCG
One occurrence in the Human Genome TACGCGCGACA, CGCGACGCATA, TCGGTACGCTA, TCGCGACCGTA, CGATCGTGCGA, CGCGTATCGGT
Two occurrences in the Human Genome CGTCGCTCGAA, TCGCGCGAATA, TCGACGCGATA, ATCGTCGACGA, CTACGCGTCGA, CGTATACGCGA, CGATTACGCGA, CGATTCGGCGA, CGACGTACCGT, CGACGAACGAG, CGCGTAATACG, CGCGCTATACG
Three occurrences in the Human Genome CGCGCATAATA, CGACGGCAGTA, CGAATCGCGTA, CGGTCGTACGA, GCGCGTACCGA, CGCGTAATCGA, CGTCGTTCGAC, CCGTCGAACGC, ACGCGCGATAT, CGAACGGTCGT, CGCGTAACGCG, CCGAATACGCG, CATATCGCGCG
Table of the number of nullomers present in different organisms and the nullomer length[4]
Organism 10bp 11bp 12bp 13bp
Arabidopsis 107 23646 1167012 20237388
C Elegans 2 7686 1152038 23339534
Chicken 2 590 131515 4722702
Chimpanzee 0 136 45938 2426474
Cow 0 96 45060 2432554
Dog 0 40 25217 1868964
Fruitfly 0 206 221616 12399300
Human 0 80 39852 2232448
Mouse 0 178 54383 2625646
Rat 0 50 30708 1933220
Zebrafish 0 2 15561 2469558

Cancer Treatment[edit]

Nullomers have been used as an approach to drug discovery and development. Nullomer peptides were screened for anti-cancer action. Absent sequences have short polyarginine tails added to increase solubility and uptake into the cell, producing peptides called PolyArgNulloPs. One successful sequence, RRRRRNWMWC, was demonstrated to have lethal effects in breast and prostate cancer. It damaged mitochondria by increasing ROS production, which reduced ATP production, leading to cell growth inhibition and cell death. Normal cells show a decreased sensitivity to PolyArgNulloPs over time.[2]

Forensics[edit]

Accidental transfer of biological material containing DNA can produce misleading results. This is a particularly important consideration in forensic and crime labs, where mistakes can cause an innocent person to be convicted of a crime. There was no way to detect if a reference sample was mislabeled as evidence or if a forensic sample is contaminated, but a nullomer barcode can be added to reference samples to distinguish them from evidence on analysis. Tagging can be carried out during sample collection without affecting genotype or quantification results. Impregnated filter paper with various nullomers can be used to soak up and store DNA samples from a crime scene, making the technology simple and effective.[3] Tagging with nullomers can be detected—even when diluted to a million-fold and spilled on evidence, these tags are still clearly detected.[3] Tagging in this way supports National Research Council's recommendations on quality control to reduce fraud and mistakes.[3]

References[edit]

  1. ^ Acquisti, Claudia; Poste, George; Curtiss, David; Kumar, Sudhir (2007). Salzberg, Steven (ed.). "Nullomers: Really a Matter of Natural Selection?". PLOS ONE. 2 (10): e1022. Bibcode:2007PLoSO...2.1022A. doi:10.1371/journal.pone.0001022. PMC 1995752. PMID 17925870. Open access icon
  • ^ a b c d Alileche, Abdelkrim; Goswami, Jayita; Bourland, William; Davis, Michael; Hampikian, Greg (2012). "Nullomer derived anticancer peptides (NulloPs): Differential lethal effects on normal and cancer cells in vitro". Peptides. 38 (2): 302–11. doi:10.1016/j.peptides.2012.09.015. PMID 23000474. S2CID 4207067.
  • ^ a b c d Goswami, Jayita; Davis, Michael C.; Andersen, Tim; Alileche, Abdelkrim; Hampikian, Greg (2013). "Safeguarding forensic DNA reference samples with nullomer barcodes". Journal of Forensic and Legal Medicine. 20 (5): 513–519. doi:10.1016/j.jflm.2013.02.003. PMID 23756524.
  • ^ a b c Hampikian, Greg; Andersen, Tim (2007). "Absent Sequences: Nullomers and Primes". Pacific Symposium on Biocomputing: 355–66. doi:10.1142/9789812772435_0034. ISBN 978-981-270-417-7. PMID 17990505.
  • ^ Cruz-Vera, Luis Rogelio; Magos-Castro, Marco Antonio; Zamora-Romo, Efraín; Guarneros, Gabriel (2004). "Ribosome stalling and peptidyl-tRNA drop-off during translational delay at AGA codons". Nucleic Acids Research. 32 (15): 4462–8. doi:10.1093/nar/gkh784. PMC 516057. PMID 15317870.
  • ^ dos Reis, Mario; Savva, Renos; Wernisch, Lorenz (2004). "Solving the riddle of codon usage preferences: A test for translational selection". Nucleic Acids Research. 32 (17): 5036–44. doi:10.1093/nar/gkh834. PMC 521650. PMID 15448185.
  • ^ Friedman, Keith A.; Heller, Adam (2001). "On the Non-Uniform Distribution of Guanine in Introns of Human Genes: Possible Protection of Exons against Oxidation by Proximal Intron Poly-G Sequences". The Journal of Physical Chemistry B. 105 (47): 11859–65. doi:10.1021/jp012043n.
  • ^ Koulouras, Grigorios; Frith, Martin C (2021-04-06). "Significant non-existence of sequences in genomes and proteomes". Nucleic Acids Research. 49 (6): 3139–3155. doi:10.1093/nar/gkab139. ISSN 0305-1048. PMC 8034619. PMID 33693858.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Nullomers&oldid=1088692717"

    Categories: 
    Amino acids
    DNA
    Genetics techniques
    Genomics
    Human mitochondrial genetics
    Nucleotides
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
     



    This page was last edited on 19 May 2022, at 16:20 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki